Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anna Spreafico

Showing results (31-40 of 186) with videos related to

Pageof 19
Sort By:
Journal of the National Cancer Institute|February 22, 2021
Underreporting of Symptomatic Adverse Events in Phase I Clinical TrialsZachary W Veitch, Daniel Shepshelovich, Christina Gallagher, et al.
JCO Oncology Practice|April 1, 2022
Turnaround Times in Melanoma BRAF Testing and the Impact on the Initiation of Systemic Therapy at a Single Tertiary Care Cancer CenterDiana Paola Arteaga Ceballos, Zaid Saeed-Kamil, Ian King, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 19, 2006
Quality of life assessment in advanced pancreatic adenocarcinoma: results from a phase III randomized trialMichele Reni, Elisa Bonetto, Stefano Cordio, et al.
Journal for Immunotherapy of Cancer|May 8, 2026
Phase 1 multicenter study of the NKG2A targeting antibody S095029 as a single agent and in combination with anti-PD-1 in patients with advanced malignanciesAung Naing, Anna Spreafico, Minal Barve, et al.
Targeted Oncology|May 31, 2022
A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket StudyAbdulazeez Salawu, Aaron R Hansen, Anna Spreafico, et al.
Head & Neck|July 8, 2022
Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancerGhazal Haddad, Katrina Hueniken, Maria Christine Xu, et al.
Nutrition and Cancer|May 27, 2023
Associations between Human Papillomavirus Status, Weight Change, and Survival of Oropharyngeal Cancer PatientsSheilla de Oliveira Faria, Katrina Hueniken, Vijay Kunaratnam, et al.
British Journal of Cancer|August 25, 2022
Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAEGeoffrey A Watson, Zachary W Veitch, Daniel Shepshelovich, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Assessment of ecological fidelity of human microbiome-associated mice in observational studies and an interventional trialMatthew K Wong, Eric Armstrong, Alya A Heirali, et al.
Mbio|September 25, 2025
Assessment of ecological fidelity of human microbiome-associated mice in observational studies and an interventional trialMatthew K Wong, Eric Armstrong, Alya A Heirali, et al.
Pageof 19

Showing results (31-40 of 186) with videos related to

Sort By:
Pageof 19
Journal of the National Cancer Institute|February 22, 2021
Underreporting of Symptomatic Adverse Events in Phase I Clinical TrialsZachary W Veitch, Daniel Shepshelovich, Christina Gallagher, et al.
JCO Oncology Practice|April 1, 2022
Turnaround Times in Melanoma BRAF Testing and the Impact on the Initiation of Systemic Therapy at a Single Tertiary Care Cancer CenterDiana Paola Arteaga Ceballos, Zaid Saeed-Kamil, Ian King, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|July 19, 2006
Quality of life assessment in advanced pancreatic adenocarcinoma: results from a phase III randomized trialMichele Reni, Elisa Bonetto, Stefano Cordio, et al.
Journal for Immunotherapy of Cancer|May 8, 2026
Phase 1 multicenter study of the NKG2A targeting antibody S095029 as a single agent and in combination with anti-PD-1 in patients with advanced malignanciesAung Naing, Anna Spreafico, Minal Barve, et al.
Targeted Oncology|May 31, 2022
A Phase 2 Trial of Afatinib in Patients with Solid Tumors that Harbor Genomic Aberrations in the HER family: The MOBILITY3 Basket StudyAbdulazeez Salawu, Aaron R Hansen, Anna Spreafico, et al.
Head & Neck|July 8, 2022
Association of post-treatment longitudinal symptom severity clusters with subsequent survival in oropharyngeal cancerGhazal Haddad, Katrina Hueniken, Maria Christine Xu, et al.
Nutrition and Cancer|May 27, 2023
Associations between Human Papillomavirus Status, Weight Change, and Survival of Oropharyngeal Cancer PatientsSheilla de Oliveira Faria, Katrina Hueniken, Vijay Kunaratnam, et al.
British Journal of Cancer|August 25, 2022
Evaluation of the patient experience of symptomatic adverse events on Phase I clinical trials using PRO-CTCAEGeoffrey A Watson, Zachary W Veitch, Daniel Shepshelovich, et al.
Biorxiv : the Preprint Server for Biology|March 31, 2025
Assessment of ecological fidelity of human microbiome-associated mice in observational studies and an interventional trialMatthew K Wong, Eric Armstrong, Alya A Heirali, et al.
Mbio|September 25, 2025
Assessment of ecological fidelity of human microbiome-associated mice in observational studies and an interventional trialMatthew K Wong, Eric Armstrong, Alya A Heirali, et al.
Pageof 19